Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Carta

Showing results (201-210 of 269) with videos related to

Pageof 27
Sort By:
Bioorganic & Medicinal Chemistry|July 12, 2016
Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory propertiesMurat Bozdag, Ahmed M Alafeefy, Fabrizio Carta, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 11, 2018
Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae α- and β-class enzymesSilvia Bua, Emanuela Berrino, Sonia Del Prete, et al.
European Journal of Medicinal Chemistry|June 12, 2026
First-in-class nonsteroidal anti-inflammatory drug and carbonic anhydrase inhibitor hybrid compounds as effective antimycobacterial agentsJenny Parkkinen, Özlem Akgul, Emanuela Berrino, et al.
Journal of Medicinal Chemistry|May 11, 2018
Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Management of Rheumatoid ArthritisOzlem Akgul, Lorenzo Di Cesare Mannelli, Daniela Vullo, et al.
Molecules (Basel, Switzerland)|February 13, 2025
In Vitro CO-Releasing and Antioxidant Properties of Sulfonamide-Based CAI-CORMs in a H<sub>2</sub>O<sub>2</sub>-Stimulated Human Achilles Tendon-Derived Cell ModelEmanuela Berrino, Paolo Guglielmi, Fabrizio Carta, et al.
Chemmedchem|September 12, 2023
Antimalarial Agents Targeting Plasmodium falciparum Carbonic Anhydrase: Towards Artesunate Hybrid Compounds with Dual Mechanism of ActionIlaria D'Agostino, Susi Zara, Simone Carradori, et al.
Journal of Medicinal Chemistry|January 10, 2023
First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced NeuropathyAndrea Angeli, Laura Micheli, Fabrizio Carta, et al.
Antioxidants (Basel, Switzerland)|January 20, 2021
Dual Carbonic Anhydrase IX/XII Inhibitors and Carbon Monoxide Releasing Molecules Modulate LPS-Mediated Inflammation in Mouse MacrophagesEmanuela Berrino, Simone Carradori, Andrea Angeli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 3, 2017
Inhibition of the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamatesAlessio Nocentini, Daniela Vullo, Sonia Del Prete, et al.
Bioorganic & Medicinal Chemistry|May 28, 2013
Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastomaHarun M Said, Carsten Hagemann, Fabrizio Carta, et al.
Pageof 27

Showing results (201-210 of 269) with videos related to

Sort By:
Pageof 27
Bioorganic & Medicinal Chemistry|July 12, 2016
Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory propertiesMurat Bozdag, Ahmed M Alafeefy, Fabrizio Carta, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 11, 2018
Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae α- and β-class enzymesSilvia Bua, Emanuela Berrino, Sonia Del Prete, et al.
European Journal of Medicinal Chemistry|June 12, 2026
First-in-class nonsteroidal anti-inflammatory drug and carbonic anhydrase inhibitor hybrid compounds as effective antimycobacterial agentsJenny Parkkinen, Özlem Akgul, Emanuela Berrino, et al.
Journal of Medicinal Chemistry|May 11, 2018
Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Management of Rheumatoid ArthritisOzlem Akgul, Lorenzo Di Cesare Mannelli, Daniela Vullo, et al.
Molecules (Basel, Switzerland)|February 13, 2025
In Vitro CO-Releasing and Antioxidant Properties of Sulfonamide-Based CAI-CORMs in a H<sub>2</sub>O<sub>2</sub>-Stimulated Human Achilles Tendon-Derived Cell ModelEmanuela Berrino, Paolo Guglielmi, Fabrizio Carta, et al.
Chemmedchem|September 12, 2023
Antimalarial Agents Targeting Plasmodium falciparum Carbonic Anhydrase: Towards Artesunate Hybrid Compounds with Dual Mechanism of ActionIlaria D'Agostino, Susi Zara, Simone Carradori, et al.
Journal of Medicinal Chemistry|January 10, 2023
First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced NeuropathyAndrea Angeli, Laura Micheli, Fabrizio Carta, et al.
Antioxidants (Basel, Switzerland)|January 20, 2021
Dual Carbonic Anhydrase IX/XII Inhibitors and Carbon Monoxide Releasing Molecules Modulate LPS-Mediated Inflammation in Mouse MacrophagesEmanuela Berrino, Simone Carradori, Andrea Angeli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 3, 2017
Inhibition of the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamatesAlessio Nocentini, Daniela Vullo, Sonia Del Prete, et al.
Bioorganic & Medicinal Chemistry|May 28, 2013
Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastomaHarun M Said, Carsten Hagemann, Fabrizio Carta, et al.
Pageof 27